Initial evaluation of extracorporeal immunomodulatory therapy for the treatment of critically ill COVID-19 infected patients

Abstract Severe COVID-19 infection results in significant immune dysregulation resulting from excessive recruitment and activation of neutrophils. The aim of this study was to confirm feasibility, initial safety and detect signal of efficacy of a non-propriety device delivered using an intermittent...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Sandrine Lemoine, Jarrin Penny, Douglas D. Fraser, Fabio R. Salerno, Justin Dorie, Tanya Tamasi, Robert Arntfield, Andrew House, Marat Slessarev, Christopher W. McIntyre
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Nature Portfolio 2022-11-01
Saila:	Scientific Reports
Sarrera elektronikoa:	https://doi.org/10.1038/s41598-022-21944-4
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!